| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Healthcare Disparities | 18 | 2022 | 165 | 4.620 |
Why?
|
| Medicare | 15 | 2022 | 206 | 3.770 |
Why?
|
| Papillomavirus Vaccines | 8 | 2021 | 44 | 3.180 |
Why?
|
| Hospitalization | 12 | 2022 | 463 | 2.730 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 168 | 2.530 |
Why?
|
| Continental Population Groups | 12 | 2020 | 236 | 2.490 |
Why?
|
| Health Care Reform | 11 | 2019 | 44 | 2.360 |
Why?
|
| Patient Readmission | 13 | 2022 | 113 | 2.290 |
Why?
|
| Vaccination | 7 | 2021 | 136 | 2.160 |
Why?
|
| Insurance Coverage | 11 | 2022 | 75 | 2.130 |
Why?
|
| Papillomavirus Infections | 7 | 2021 | 65 | 2.100 |
Why?
|
| United States | 45 | 2022 | 3925 | 2.060 |
Why?
|
| Hospital Mortality | 6 | 2019 | 190 | 2.030 |
Why?
|
| Ethnic Groups | 10 | 2020 | 476 | 1.960 |
Why?
|
| Emergency Service, Hospital | 6 | 2021 | 471 | 1.680 |
Why?
|
| Health Status Disparities | 6 | 2019 | 122 | 1.510 |
Why?
|
| Humans | 77 | 2022 | 31836 | 1.380 |
Why?
|
| Myocardial Infarction | 8 | 2019 | 480 | 1.320 |
Why?
|
| Aged | 37 | 2022 | 10288 | 1.310 |
Why?
|
| Female | 58 | 2020 | 19859 | 1.270 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 178 | 1.240 |
Why?
|
| Chronic Disease | 3 | 2018 | 400 | 1.200 |
Why?
|
| Medically Uninsured | 7 | 2019 | 31 | 1.160 |
Why?
|
| Condylomata Acuminata | 2 | 2017 | 7 | 1.120 |
Why?
|
| Quality Indicators, Health Care | 6 | 2016 | 59 | 1.100 |
Why?
|
| Male | 49 | 2020 | 19091 | 1.090 |
Why?
|
| Quality of Health Care | 5 | 2016 | 147 | 1.060 |
Why?
|
| Minority Groups | 3 | 2018 | 75 | 1.060 |
Why?
|
| Hispanic Americans | 9 | 2019 | 942 | 1.040 |
Why?
|
| Aged, 80 and over | 21 | 2020 | 3988 | 1.040 |
Why?
|
| Adolescent | 22 | 2021 | 3511 | 1.020 |
Why?
|
| Middle Aged | 38 | 2020 | 11824 | 0.970 |
Why?
|
| Retrospective Studies | 20 | 2020 | 3488 | 0.970 |
Why?
|
| Young Adult | 22 | 2020 | 2603 | 0.960 |
Why?
|
| Prospective Payment System | 2 | 2021 | 9 | 0.950 |
Why?
|
| African Americans | 9 | 2019 | 1428 | 0.930 |
Why?
|
| European Continental Ancestry Group | 11 | 2019 | 1169 | 0.900 |
Why?
|
| Insurance, Health | 7 | 2022 | 95 | 0.880 |
Why?
|
| Anticoagulants | 2 | 2021 | 122 | 0.870 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 420 | 0.860 |
Why?
|
| Meningococcal Vaccines | 3 | 2021 | 9 | 0.860 |
Why?
|
| Adult | 28 | 2020 | 9327 | 0.860 |
Why?
|
| United States Department of Veterans Affairs | 11 | 2018 | 62 | 0.850 |
Why?
|
| Heart Failure | 6 | 2021 | 620 | 0.840 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 159 | 0.810 |
Why?
|
| Ambulatory Care | 2 | 2019 | 108 | 0.770 |
Why?
|
| Health Services Accessibility | 9 | 2018 | 242 | 0.760 |
Why?
|
| Economics, Hospital | 2 | 2019 | 6 | 0.750 |
Why?
|
| Massachusetts | 13 | 2020 | 27 | 0.730 |
Why?
|
| Veterans | 2 | 2018 | 66 | 0.710 |
Why?
|
| Health Services | 2 | 2018 | 38 | 0.700 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 12 | 0.690 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 760 | 0.680 |
Why?
|
| Poverty | 3 | 2018 | 111 | 0.680 |
Why?
|
| Referral and Consultation | 2 | 2018 | 140 | 0.670 |
Why?
|
| Cohort Studies | 8 | 2021 | 1824 | 0.660 |
Why?
|
| Eligibility Determination | 2 | 2018 | 17 | 0.660 |
Why?
|
| Mammography | 1 | 2018 | 42 | 0.610 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 322 | 0.600 |
Why?
|
| Adolescent Health Services | 1 | 2017 | 12 | 0.590 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 72 | 0.590 |
Why?
|
| Ambulances | 1 | 2017 | 13 | 0.580 |
Why?
|
| Hospitals | 5 | 2022 | 98 | 0.580 |
Why?
|
| Transportation of Patients | 1 | 2017 | 26 | 0.570 |
Why?
|
| Communication Barriers | 1 | 2017 | 22 | 0.570 |
Why?
|
| Hypertension | 4 | 2020 | 956 | 0.570 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 147 | 0.570 |
Why?
|
| Language | 1 | 2017 | 42 | 0.570 |
Why?
|
| Documentation | 1 | 2016 | 46 | 0.550 |
Why?
|
| Information Dissemination | 1 | 2016 | 52 | 0.550 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2015 | 2 | 0.540 |
Why?
|
| Patient Admission | 1 | 2016 | 60 | 0.530 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 398 | 0.530 |
Why?
|
| Inpatients | 1 | 2016 | 81 | 0.530 |
Why?
|
| Radiography | 1 | 2017 | 376 | 0.530 |
Why?
|
| Health Policy | 1 | 2016 | 82 | 0.520 |
Why?
|
| Schools | 1 | 2016 | 65 | 0.520 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 17 | 0.500 |
Why?
|
| Immunization Programs | 1 | 2015 | 26 | 0.500 |
Why?
|
| Sexual Behavior | 1 | 2015 | 107 | 0.490 |
Why?
|
| Pneumonia | 5 | 2019 | 66 | 0.490 |
Why?
|
| Health Surveys | 3 | 2019 | 196 | 0.480 |
Why?
|
| Logistic Models | 5 | 2018 | 777 | 0.460 |
Why?
|
| Terminal Care | 4 | 2022 | 24 | 0.450 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2020 | 89 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2021 | 353 | 0.440 |
Why?
|
| Hospitals, Veterans | 4 | 2018 | 37 | 0.430 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2018 | 34 | 0.420 |
Why?
|
| Stroke | 2 | 2018 | 581 | 0.400 |
Why?
|
| Health Behavior | 2 | 2016 | 231 | 0.390 |
Why?
|
| Health Literacy | 3 | 2016 | 29 | 0.390 |
Why?
|
| Brain Ischemia | 1 | 2013 | 145 | 0.380 |
Why?
|
| Patient Discharge | 5 | 2019 | 183 | 0.350 |
Why?
|
| Educational Status | 3 | 2016 | 178 | 0.330 |
Why?
|
| Hospice Care | 1 | 2009 | 13 | 0.330 |
Why?
|
| United States Agency for Healthcare Research and Quality | 3 | 2013 | 5 | 0.330 |
Why?
|
| Asian Americans | 2 | 2019 | 97 | 0.320 |
Why?
|
| Medicaid | 3 | 2020 | 94 | 0.320 |
Why?
|
| Insurance Claim Review | 3 | 2020 | 27 | 0.320 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 771 | 0.310 |
Why?
|
| Health Services Research | 4 | 2018 | 82 | 0.310 |
Why?
|
| Cross-Sectional Studies | 10 | 2020 | 1527 | 0.310 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 28 | 0.310 |
Why?
|
| Income | 1 | 2008 | 61 | 0.310 |
Why?
|
| Asthma | 2 | 2022 | 298 | 0.300 |
Why?
|
| Health Care Costs | 1 | 2009 | 117 | 0.300 |
Why?
|
| Acute Disease | 2 | 2019 | 252 | 0.300 |
Why?
|
| Health Care Surveys | 2 | 2019 | 186 | 0.300 |
Why?
|
| Diabetic Angiopathies | 2 | 2018 | 143 | 0.300 |
Why?
|
| Treatment Outcome | 7 | 2020 | 3294 | 0.290 |
Why?
|
| African Continental Ancestry Group | 3 | 2016 | 363 | 0.290 |
Why?
|
| Sentinel Surveillance | 2 | 2017 | 11 | 0.280 |
Why?
|
| Child | 5 | 2021 | 2425 | 0.280 |
Why?
|
| Health Education | 3 | 2020 | 157 | 0.270 |
Why?
|
| Health Personnel | 2 | 2019 | 122 | 0.260 |
Why?
|
| Risk Factors | 7 | 2020 | 3851 | 0.250 |
Why?
|
| Patient Participation | 2 | 2016 | 80 | 0.250 |
Why?
|
| Databases, Factual | 2 | 2016 | 349 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 540 | 0.220 |
Why?
|
| Pesticides | 1 | 2016 | 200 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 233 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 291 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 245 | 0.210 |
Why?
|
| Comorbidity | 4 | 2019 | 566 | 0.210 |
Why?
|
| Age Factors | 6 | 2020 | 1187 | 0.210 |
Why?
|
| Advance Care Planning | 1 | 2022 | 15 | 0.200 |
Why?
|
| Illinois | 1 | 2021 | 10 | 0.200 |
Why?
|
| Long-Term Care | 1 | 2021 | 25 | 0.200 |
Why?
|
| Electronic Health Records | 3 | 2018 | 159 | 0.200 |
Why?
|
| Risk Adjustment | 3 | 2019 | 26 | 0.190 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 2021 | 2 | 0.190 |
Why?
|
| Parents | 2 | 2021 | 147 | 0.190 |
Why?
|
| Reproductive Health Services | 1 | 2020 | 5 | 0.190 |
Why?
|
| Women's Health Services | 1 | 2020 | 11 | 0.190 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 32 | 0.190 |
Why?
|
| Epilepsy | 2 | 2011 | 82 | 0.180 |
Why?
|
| Reimbursement, Incentive | 1 | 2019 | 11 | 0.180 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 70 | 0.170 |
Why?
|
| Prevalence | 3 | 2018 | 979 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 50 | 0.170 |
Why?
|
| Research Design | 1 | 2021 | 310 | 0.170 |
Why?
|
| Meningococcal Infections | 2 | 2019 | 6 | 0.170 |
Why?
|
| Intention | 2 | 2019 | 28 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2019 | 184 | 0.160 |
Why?
|
| Unemployment | 1 | 2018 | 4 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 288 | 0.160 |
Why?
|
| Regression Analysis | 2 | 2019 | 293 | 0.160 |
Why?
|
| Early Detection of Cancer | 2 | 2017 | 89 | 0.160 |
Why?
|
| California | 1 | 2018 | 61 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2017 | 2277 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2019 | 80 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2018 | 31 | 0.160 |
Why?
|
| Age Distribution | 1 | 2018 | 206 | 0.150 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 17 | 0.150 |
Why?
|
| Immunization Schedule | 1 | 2017 | 26 | 0.150 |
Why?
|
| Advisory Committees | 1 | 2017 | 31 | 0.150 |
Why?
|
| Acculturation | 1 | 2017 | 17 | 0.150 |
Why?
|
| Social Class | 1 | 2017 | 88 | 0.140 |
Why?
|
| Data Mining | 1 | 2016 | 10 | 0.140 |
Why?
|
| Medical Informatics | 1 | 2016 | 27 | 0.140 |
Why?
|
| Health Expenditures | 3 | 2019 | 66 | 0.140 |
Why?
|
| Organizational Policy | 1 | 2016 | 20 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2017 | 119 | 0.140 |
Why?
|
| Warfarin | 1 | 2016 | 29 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2017 | 125 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 127 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 899 | 0.130 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 9 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2015 | 16 | 0.130 |
Why?
|
| Software | 1 | 2016 | 127 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 156 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 26 | 0.130 |
Why?
|
| Hysterectomy | 1 | 2015 | 45 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 216 | 0.120 |
Why?
|
| Mass Screening | 1 | 2017 | 263 | 0.120 |
Why?
|
| Sex Factors | 4 | 2017 | 662 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2014 | 102 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2016 | 224 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2015 | 171 | 0.120 |
Why?
|
| Hepacivirus | 1 | 2013 | 39 | 0.110 |
Why?
|
| Algorithms | 1 | 2016 | 495 | 0.110 |
Why?
|
| Residence Characteristics | 2 | 2011 | 191 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 77 | 0.110 |
Why?
|
| Costs and Cost Analysis | 3 | 2021 | 100 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2013 | 108 | 0.110 |
Why?
|
| Time Factors | 4 | 2020 | 2146 | 0.100 |
Why?
|
| Continuity of Patient Care | 2 | 2013 | 69 | 0.100 |
Why?
|
| New Jersey | 3 | 2016 | 9 | 0.100 |
Why?
|
| New York | 3 | 2016 | 21 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2010 | 195 | 0.100 |
Why?
|
| Terminally Ill | 1 | 2010 | 1 | 0.090 |
Why?
|
| Nursing Homes | 1 | 2010 | 42 | 0.090 |
Why?
|
| Hospital Administration | 1 | 2009 | 13 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2271 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1158 | 0.080 |
Why?
|
| Safety Management | 1 | 2009 | 37 | 0.080 |
Why?
|
| Survival Rate | 1 | 2010 | 884 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 504 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2008 | 225 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 185 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 1192 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 895 | 0.060 |
Why?
|
| Quality of Life | 2 | 2022 | 924 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 103 | 0.050 |
Why?
|
| Hospital-Physician Relations | 1 | 2021 | 5 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 764 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2014 | 173 | 0.050 |
Why?
|
| Contraception | 1 | 2020 | 13 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2020 | 49 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 54 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2022 | 279 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 24 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 40 | 0.040 |
Why?
|
| Occult Blood | 1 | 2017 | 9 | 0.040 |
Why?
|
| New York City | 1 | 2017 | 14 | 0.040 |
Why?
|
| Boston | 1 | 2017 | 15 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2019 | 161 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2017 | 45 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2016 | 8 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 397 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 30 | 0.030 |
Why?
|
| Markov Chains | 1 | 2016 | 29 | 0.030 |
Why?
|
| Executive Function | 1 | 2016 | 57 | 0.030 |
Why?
|
| Alcoholism | 1 | 2017 | 101 | 0.030 |
Why?
|
| Endometrial Hyperplasia | 1 | 2015 | 14 | 0.030 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2015 | 7 | 0.030 |
Why?
|
| Laparotomy | 1 | 2015 | 30 | 0.030 |
Why?
|
| Software Design | 1 | 2015 | 7 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 136 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2016 | 100 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 89 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 83 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 370 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 318 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 94 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 315 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 404 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 8 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 10 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 7 | 0.030 |
Why?
|
| Proline | 1 | 2013 | 12 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 916 | 0.030 |
Why?
|
| Interferons | 1 | 2013 | 17 | 0.030 |
Why?
|
| Ribavirin | 1 | 2013 | 28 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2013 | 16 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2013 | 45 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 470 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 62 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 85 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 284 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2011 | 9 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 487 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 105 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 148 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 65 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 727 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2011 | 2 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2011 | 10 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 257 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2010 | 13 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2009 | 26 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 874 | 0.020 |
Why?
|